Vaccine stocks January 2022
Shares are currently going under, but how will it go from here?
Many COVID-19 vaccine stocks have fallen more sharply in the past few days. I have summarized the reasons for this for you in this article. In 2022, the pandemic is likely to slowly ebb. The first Omikron studies show a falling hospital admission rate. In addition, Biontech and other companies are already developing customized vaccines.
Vaccine stocks compared
Trade Team Forecast
If you want to bet on a Covid-19 vaccine stock, then we recommend Moderna Inc. In the last quarter, Moderna reported sales of almost 5 billion US dollars, which corresponds to a breathtaking increase of 3,000% year-on-year.
We think vaccine stocks will come back and make good profit last time.